These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22876054)

  • 1. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome.
    Jeong JS; Kim HK; Lee CR; Park S; Park JH; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    J Korean Med Sci; 2012 Aug; 27(8):883-9. PubMed ID: 22876054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.
    Ryu YJ; Yoon JH
    Surg Oncol; 2020 Sep; 34():67-73. PubMed ID: 32891356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer.
    Zhang Y; Ma XP; Deng FS; Liu ZR; Wei HQ; Wang XH; Chen H
    World J Surg Oncol; 2014 Sep; 12():277. PubMed ID: 25179111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
    Heo DB; Won HR; Tae K; Kang YE; Jeon E; Ji YB; Chang JW; Choi JY; Yu HW; Ku EJ; Lee EK; Kim M; Choe JH; Koo BS;
    Surgery; 2024 Apr; 175(4):1049-1054. PubMed ID: 38281855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.
    Yoon YH; Kim HJ; Lee JW; Kim JM; Koo BS
    Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1013-7. PubMed ID: 21822854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.
    Kim WW; Ha TK; Bae SK
    J Otolaryngol Head Neck Surg; 2018 Jan; 47(1):4. PubMed ID: 29316976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
    Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
    Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma.
    Jara SM; Carson KA; Pai SI; Agrawal N; Richmon JD; Prescott JD; Dackiw A; Zeiger MA; Bishop JA; Tufano RP
    Surgery; 2013 Dec; 154(6):1272-80; discussion 1280-2. PubMed ID: 24238047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
    Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer.
    Sakiz D; Sencar ME; Calapkulu M; Ozturk Unsal I; Aktas L; Ucan B; Ozbek M; Cakal E
    Endocr Pract; 2021 Dec; 27(12):1199-1204. PubMed ID: 34293511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes.
    Pilli T; Toti P; Occhini R; Castagna MG; Cantara S; Caselli M; Cardinale S; Barbagli L; Pacini F
    J Endocrinol Invest; 2018 Jun; 41(6):703-709. PubMed ID: 29230715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients.
    Ma B; Chen X; Zhao Z; Yin X; Ji Q; Zhou Y; Ma C; Wang J
    BMC Endocr Disord; 2022 Mar; 22(1):55. PubMed ID: 35255870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study.
    Nam HY; Lee HY; Park GC
    Clin Otolaryngol; 2016 Aug; 41(4):358-64. PubMed ID: 26283460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.
    Lee I; Kim HK; Soh EY; Lee J
    World J Surg; 2020 May; 44(5):1506-1513. PubMed ID: 31915977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
    Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
    Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.
    Song E; Jeon MJ; Park S; Kim M; Oh HS; Song DE; Kim WG; Kim WB; Shong YK; Kim TY
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):123-128. PubMed ID: 28906015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma.
    Kim HG; Kim EK; Han KH; Kim H; Kwak JY
    Yonsei Med J; 2014 Jul; 55(4):879-85. PubMed ID: 24954314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.